Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in Western countries.
There is increasing recognition in the value of using RWD alongside RCT data to generate a baseline understanding of the efficacy of treatments for CLL in the real world. As this would allow for a better understanding of unmet needs and inform future comparative effectiveness studies.
View overview page